Werewolf Therapeutics (HOWL) Q2 2024 Earnings

3MayConfirmed
Q2 2023
Q3 2023
Q4 2023
Q2 2024
-0.42
-0.28
-0.14
0

Details

Expected EPS
-0.342
Actual EPS
-0.39
Surprise EPS
-0.05
Surprise Percent
+14.04%

Description

Werewolf Therapeutics (HOWL) has reported earnings of -0.39 per share for Q2 2024.

0 Comments

Share your thoughts